People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Health Care, Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Goldcup 12446 AB | — | Other Health Care | Series B | $29.7M | $657.1M | 2016 |
| Meadowhawk Biolabs, Inc. | — | Biotechnology | Series A | $20.3M | $26.3M | 2021 |
| Victory Pharma Inc | — | Pharmaceuticals | Series A | $10.0M | $309.7M | 2009 |
Herbert Hooper at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Herbert Hooper on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Parker | 2 | 11 |
| David Snyder | 1 | 5 |
| Scott Barry | 1 | 4 |
| Thomas Wiggans | 1 | 3 |
| Magnus Persson | 1 | 3 |
| Matthew Heck | 1 | 2 |
| James Newman | 1 | 2 |
| Hans Andreasson | 1 | 2 |
| Daniel Stokely | 1 | 1 |
| Peter Glick | 1 | 1 |
| James Jersey | 1 | 1 |
| Jessica Sullivan | 1 | 1 |
| Glick Peter | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.